Recombinant multi-species RDH12 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RDH12 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is an NADPH-dependent retinal reductase whose highest activity is toward 9-cis and all-trans-retinol. The encoded enzyme also plays a role in the metabolism of short-chain aldehydes but does not exhibit steroid dehydrogenase activity. Defects in this gene are a cause of Leber congenital amaurosis type 13 and Retinitis Pigmentosa 53. [provided by RefSeq, Sep 2015]
The Alternative Names of target: All-trans and 9-cis retinol dehydrogenase,DSSDR2,LCA13,RDH12,RP53,Rdh12,Retinol dehydrogenase 12,SDR7C2,Short chain dehydrogenase/reductase family 7C member 2

Target products collectionGo to RDH12 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1513-Ag-1/ GM-Tg-hg-SE1513-Ag-2 Human RDH12 protein Human
GM-Tg-rg-SE1513-Ag-1/ GM-Tg-rg-SE1513-Ag-2 Rat RDH12 protein Rat
GM-Tg-mg-SE1513-Ag-1/ GM-Tg-mg-SE1513-Ag-2 Mouse RDH12 protein Mouse
GM-Tg-cynog-SE1513-Ag-1/ GM-Tg-cynog-SE1513-Ag-2 Cynomolgus/Rhesus macaque RDH12 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1513-Ag-1/ GM-Tg-felg-SE1513-Ag-2 Feline RDH12 protein Feline
GM-Tg-cang-SE1513-Ag-1/ GM-Tg-cang-SE1513-Ag-2 Canine RDH12 protein Canine
GM-Tg-bovg-SE1513-Ag-1/ GM-Tg-bovg-SE1513-Ag-2 Bovine RDH12 protein Bovine
GM-Tg-equg-SE1513-Ag-1/ GM-Tg-equg-SE1513-Ag-2 Equine RDH12 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1513-Ag-1/ GM-Tg-hg-SE1513-Ag-2; GM-Tg-rg-SE1513-Ag-1/ GM-Tg-rg-SE1513-Ag-2;
GM-Tg-mg-SE1513-Ag-1/ GM-Tg-mg-SE1513-Ag-2; GM-Tg-cynog-SE1513-Ag-1/ GM-Tg-cynog-SE1513-Ag-2;
GM-Tg-felg-SE1513-Ag-1/ GM-Tg-felg-SE1513-Ag-2; GM-Tg-cang-SE1513-Ag-1/ GM-Tg-cang-SE1513-Ag-2;
GM-Tg-bovg-SE1513-Ag-1/ GM-Tg-bovg-SE1513-Ag-2; GM-Tg-equg-SE1513-Ag-1/ GM-Tg-equg-SE1513-Ag-2
Products Name RDH12 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RDH12
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RDH12 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.